Periodontitis and mechanisms of cardiometabolic risk: Novel insights and future perspectives |
| |
| Authors: | Francisco Mesa Antonio Magan-Fernandez Giuseppa Castellino Roberta Chianetta Luigi Nibali Manfredi Rizzo |
| |
| Institution: | 1. Periodontology Department, School of Dentistry, University of Granada, Granada, Spain.;2. Biomedical Department of Internal Medicine and Specialties, University of Palermo, Italy.;3. Centre for Oral Immunobiology & Regenerative Medicine, Centre for Oral Clinical Research, Institute of Dentistry, Bart''s and the London School of Medicine and Dentistry, Queen Mary University of London (QMUL), London, UK |
| |
| Abstract: | Periodontitis is an infectious and inflammatory disease of the tooth-supporting tissues caused by the accumulation of subgingival plaque and the action of specific periodontopathogenic bacteria. Periodontitis has been associated with cardiovascular diseases and considered a cardiovascular risk factor. Several mechanisms have been proposed to explain this association, such as the infection of atherosclerotic plaques by periodontal pathogens, the pro-atherogenic effect on the lipid profile, the systemic dissemination of pro-inflammatory mediators or the contribution to type 2 diabetes mellitus. Periodontal treatment has also been related to improvement in cardiometabolic risk variables, and oral hygiene techniques may be useful in reducing cardiometabolic risk. The aim of this review is to provide new and recent insights on the relationship between periodontitis and cardiometabolic risk, focusing on recent evidence. Comments on shared potential therapeutic targets, such as the role of glucagon-like peptide 1, are also highlighted. |
| |
| Keywords: | Cardiovascular diseases Periodontitis Atherosclerosis Microbiota Glucagon-like peptide 1 |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
